Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.54
+0.03 (0.40%)
At close: Apr 28, 2026, 4:00 PM EDT
7.60
+0.06 (0.80%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Puma Biotechnology Market Cap
Puma Biotechnology has a market cap or net worth of $383.61 million as of April 29, 2026. Its market cap has increased by 174.20% in one year.
Market Cap
383.61M
Enterprise Value
314.63M
1-Year Change
174.20%
Ranking
Category
Stock Price
$7.54
Market Cap Chart
Since April 24, 2012, Puma Biotechnology's market cap has increased from $280.60M to $383.61M, an increase of 36.71%. That is a compound annual growth rate of 2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 383.60M | 27.95% |
| Dec 31, 2025 | 299.80M | 100.27% |
| Dec 31, 2024 | 149.70M | -27.33% |
| Dec 29, 2023 | 206.00M | 6.68% |
| Dec 30, 2022 | 193.10M | 55.35% |
| Dec 31, 2021 | 124.30M | -69.53% |
| Dec 31, 2020 | 408.00M | 19.68% |
| Dec 31, 2019 | 340.90M | -56.07% |
| Dec 31, 2018 | 776.00M | -79.08% |
| Dec 29, 2017 | 3.71B | 228.21% |
| Dec 30, 2016 | 1.13B | -55.55% |
| Dec 31, 2015 | 2.54B | -55.43% |
| Dec 31, 2014 | 5.71B | 92.11% |
| Dec 31, 2013 | 2.97B | 452.60% |
| Dec 31, 2012 | 537.50M | 91.55% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 399.73M |
| Niagen Bioscience | 395.62M |
| Immuneering | 390.77M |
| Enanta Pharmaceuticals | 386.25M |
| Lineage Cell Therapeutics | 386.09M |
| Rocket Pharmaceuticals | 384.11M |
| YD Bio | 383.95M |
| Autolus Therapeutics | 383.25M |